Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.24.2.u1
Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Common Shares Issuable
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2022 $ 3 $ 7   $ 675,944 $ (634,233) $ 8,304 $ 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 7,366,283          
Stock-based compensation expense       8,948     8,948
Issuance of common stock related to equity plans (in shares)   183,856          
Issuance of common stock for public offering, net   $ 2   13,152     13,154
Issuance of stock for public offerings, net (in shares)   1,109,526          
Issuance of common stock under ESPP       88     88
Issuance of common stock for at-the-market offering, net       1,168     1,168
Issuance of common stock for at-the-market offering, net (in shares)   106,425          
Common shares issued for dividend on partner company's convertible preferred shares     $ 23 108     131
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   11,066          
Partner company's offering, net       21,977     21,977
Partner company's exercise of options for cash       3     3
Preferred A dividends declared and paid       (4,016)     (4,016)
Partner company's dividends declared and paid       (371)     (371)
Issuance of partner company's common shares for research and development expenses       1,233     1,233
Warrants       272     272
Deconsolidation/dissolution of subsidiary non-controlling interests           5,891 5,891
Non-controlling interest in partner companies       (19,486)   19,486  
Net loss attributable to non-controlling interest           (68,133) (68,133)
Net loss attributable to common stockholders         (46,313)   (46,313)
Balance at Jun. 30, 2023 $ 3 $ 9 23 699,020 (680,546) (34,452) (15,943)
Balance (in shares) at Jun. 30, 2023 3,427,138 8,777,156          
Balance at Mar. 31, 2023 $ 3 $ 9   693,554 (655,770) (17,990) 19,806
Balance (in shares) at Mar. 31, 2023 3,427,138 8,694,477          
Stock-based compensation expense       4,217     4,217
Issuance of common stock related to equity plans (in shares)   5,515          
Issuance of common stock for public offering, net       (41)     (41)
Issuance of common stock for at-the-market offering, net       721     721
Issuance of common stock for at-the-market offering, net (in shares)   66,098          
Common shares issued for dividend on partner company's convertible preferred shares     23 108     131
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   11,066          
Partner company's offering, net       14,460     14,460
Partner company's exercise of options for cash       3     3
Issuance of common stock under partner company's ESPP       88     88
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's dividends declared and paid       (185)     (185)
Issuance of partner company's common shares for research and development expenses       3     3
Partner company's warrants issued in conjunction with debt       272     272
Deconsolidation/dissolution of subsidiary non-controlling interests           5,891 5,891
Non-controlling interest in partner companies       (12,172)   12,172  
Net loss attributable to non-controlling interest           (34,525) (34,525)
Net loss attributable to common stockholders         (24,776)   (24,776)
Balance at Jun. 30, 2023 $ 3 $ 9 $ 23 699,020 (680,546) (34,452) (15,943)
Balance (in shares) at Jun. 30, 2023 3,427,138 8,777,156          
Balance at Dec. 31, 2023 $ 3 $ 15   717,396 (694,870) (20,957) 1,587
Balance (in shares) at Dec. 31, 2023 3,427,138 15,093,053          
Stock-based compensation expense       9,856     9,856
Issuance of common stock related to equity plans (in shares)   495,761          
Issuance of common stock for public offering, net   $ 3   10,115     10,118
Issuance of stock for public offerings, net (in shares)   3,303,305          
Issuance of common stock under ESPP       51     51
Issuance of common stock under ESPP (in shares)   29,844          
Issuance of common stock for at-the-market offering, net   $ 2   2,824     2,826
Issuance of common stock for at-the-market offering, net (in shares)   1,554,483          
Common shares issued for dividend on partner company's convertible preferred shares       114     114
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   64,747          
Common shares issued for exchange of partner company's convertible preferred shares   $ 3   3,406     3,409
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345          
Exercise of warrants for cash       30     30
Exercise of warrants for cash (in shares)   17,500          
Partner company's offering, net       18,002     18,002
Partner company's at-the-market offering, net       1,779     1,779
Warrants issued in conjunction with exchange of partner company's convertible preferred shares       341     341
Issuance of common stock under partner company's ESPP       133     133
Preferred A dividends declared and paid       (4,016)     (4,016)
Partner company's dividends declared and paid       (352)     (352)
Exercise of partner company options and warrants for cash, net       9,370     9,370
Non-controlling interest in partner companies       (29,963)   29,963  
Net loss attributable to non-controlling interest           (41,481) (41,481)
Net loss attributable to common stockholders         (26,365)   (26,365)
Balance at Jun. 30, 2024 $ 3 $ 23   739,086 (721,235) (32,475) (14,598)
Balance (in shares) at Jun. 30, 2024 3,427,138 22,587,038          
Balance at Mar. 31, 2024 $ 3 $ 19   733,290 (710,287) (26,962) (3,937)
Balance (in shares) at Mar. 31, 2024 3,427,138 19,375,343          
Stock-based compensation expense       4,998     4,998
Issuance of common stock related to equity plans (in shares)   34,293          
Issuance of common stock under ESPP       51     51
Issuance of common stock under ESPP (in shares)   29,844          
Issuance of common stock for at-the-market offering, net   $ 1   1,930     1,931
Issuance of common stock for at-the-market offering, net (in shares)   1,092,283          
Common shares issued for dividend on partner company's convertible preferred shares       46     46
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   26,930          
Common shares issued for exchange of partner company's convertible preferred shares   $ 3   3,406     3,409
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345          
Partner company's offering, net       5,265     5,265
Partner company's at-the-market offering, net       295     295
Warrants issued in conjunction with exchange of partner company's convertible preferred shares       341     341
Partner companies' proceeds from options and warrants, net       4,010     4,010
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's dividends declared and paid       (176)     (176)
Non-controlling interest in partner companies       (12,363)   12,363  
Net loss attributable to non-controlling interest           (17,876) (17,876)
Net loss attributable to common stockholders         (10,948)   (10,948)
Balance at Jun. 30, 2024 $ 3 $ 23   $ 739,086 $ (721,235) $ (32,475) $ (14,598)
Balance (in shares) at Jun. 30, 2024 3,427,138 22,587,038